关注
Allison Betof Warner, MD, PhD
Allison Betof Warner, MD, PhD
Stanford Cancer Institute
在 stanford.edu 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
The future of cancer immunotherapy: microenvironment-targeting combinations
YR Murciano-Goroff, AB Warner, JD Wolchok
Cell Research 30 (6), 507-519, 2020
6012020
Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma
MH Pollack, A Betof, H Dearden, K Rapazzo, I Valentine, AS Brohl, ...
Annals of Oncology 29 (1), 250-255, 2018
3472018
Modulation of murine breast tumor vascularity, hypoxia, and chemotherapeutic response by exercise
AS Betof, CD Lascola, D Weitzel, C Landon, PM Scarbrough, GR Devi, ...
Journal of the National Cancer Institute 107 (5), djv040, 2015
2932015
Effects and potential mechanisms of exercise training on cancer progression: a translational perspective
AS Betof, MW Dewhirst, LW Jones
Brain, behavior, and immunity 30, S75-S87, 2013
2752013
Efficacy and mechanisms of aerobic exercise on cancer initiation, progression, and metastasis: a critical systematic review of in vivo preclinical data
KA Ashcraft, RM Peace, AS Betof, MW Dewhirst, LW Jones
Cancer research 76 (14), 4032-4050, 2016
2332016
Neoadjuvant relatlimab and nivolumab in resectable melanoma
RN Amaria, M Postow, EM Burton, MT Tetzlaff, MI Ross, C Torres-Cabala, ...
Nature 611 (7934), 155-160, 2022
1792022
Impact of age on outcomes with immunotherapy for patients with melanoma
AS Betof, RD Nipp, A Giobbie‐Hurder, RAN Johnpulle, K Rubin, ...
The oncologist 22 (8), 963-971, 2017
1732017
Exercise modulation of the host-tumor interaction in an orthotopic model of murine prostate cancer
LW Jones, J Antonelli, EM Masko, G Broadwater, CD Lascola, D Fels, ...
Journal of applied physiology 113 (2), 263-272, 2012
1732012
Long-term outcomes and responses to retreatment in patients with melanoma treated with PD-1 blockade
A Betof Warner, JS Palmer, AN Shoushtari, DA Goldman, KS Panageas, ...
Journal of Clinical Oncology 38 (15), 1655-1663, 2020
1622020
Exercise as Adjunct Therapy in Cancer
KA Ashcraft, AB Warner, LW Jones, MW Dewhirst
Seminars in radiation oncology 29 (1), 16-24, 2019
1572019
Ipilimumab alone or ipilimumab plus anti-PD-1 therapy in patients with metastatic melanoma resistant to anti-PD-(L) 1 monotherapy: a multicentre, retrospective, cohort study
IP da Silva, T Ahmed, ILM Reijers, AM Weppler, AB Warner, JR Patrinely, ...
The Lancet Oncology 22 (6), 836-847, 2021
1392021
Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors
AC Guidon, LB Burton, BK Chwalisz, J Hillis, TH Schaller, AA Amato, ...
Journal for immunotherapy of cancer 9 (7), 2021
1282021
Effect of pazopanib on tumor microenvironment and liposome delivery
TD Tailor, G Hanna, PS Yarmolenko, MR Dreher, AS Betof, AB Nixon, ...
Molecular cancer therapeutics 9 (6), 1798-1808, 2010
1212010
Early use of high-dose glucocorticoid for the management of irAE is associated with poorer survival in patients with advanced melanoma treated with anti–PD-1 monotherapy
X Bai, J Hu, A Betof Warner, HT Quach, CG Cann, MZ Zhang, L Si, B Tang, ...
Clinical Cancer Research 27 (21), 5993-6000, 2021
1062021
Peripheral blood clinical laboratory variables associated with outcomes following combination nivolumab and ipilimumab immunotherapy in melanoma
S Rosner, E Kwong, AN Shoushtari, CF Friedman, AS Betof, MS Brady, ...
Cancer medicine 7 (3), 690-697, 2018
1042018
A phase I/II study of neoadjuvant liposomal doxorubicin, paclitaxel, and hyperthermia in locally advanced breast cancer
Z Vujaskovic, DW Kim, E Jones, L Lan, L McCall, MW Dewhirst, ...
International Journal of Hyperthermia 26 (5), 514-521, 2010
1022010
T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants
D Hirschhorn, S Budhu, L Kraehenbuehl, M Gigoux, D Schröder, A Chow, ...
Cell 186 (7), 1432-1447. e17, 2023
942023
Selective inhibition of low-affinity memory CD8+ T cells by corticosteroids
A Tokunaga, D Sugiyama, Y Maeda, AB Warner, KS Panageas, S Ito, ...
Journal of Experimental Medicine 216 (12), 2701-2713, 2019
942019
Randomized phase II trial of proton craniospinal irradiation versus photon involved-field radiotherapy for patients with solid tumor leptomeningeal metastasis
JT Yang, NA Wijetunga, E Pentsova, S Wolden, RJ Young, D Correa, ...
Journal of Clinical Oncology 40 (33), 3858-3867, 2022
712022
LAG-3 expression on peripheral blood cells identifies patients with poorer outcomes after immune checkpoint blockade
R Shen, MA Postow, M Adamow, A Arora, M Hannum, C Maher, P Wong, ...
Science Translational Medicine 13 (608), eabf5107, 2021
672021
系统目前无法执行此操作,请稍后再试。
文章 1–20